Humalog (insulin lispro) and Humulin N (insulin isophane human) are brand-name prescription* medications. They’re approved by the Food and Drug Administration (FDA) to help treat type 1 and type 2 ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

INDIANAPOLIS, Oct. 27 Eli Lilly and Company(NYSE: LLY) today announced the introduction of a color differentiation systemfor U-100 insulin products marketed in the United States, including vials,pens ...

DANBURY, CT--(Marketwired - August 11, 2014) - Biodel Inc. (BIOD) announced positive preliminary results from Study 3-152, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated ...

Humalog is given as an injection, and there are two types of the drug: Some forms of Humalog and Humalog Mix are available as generics or biosimilars. To learn more, see “Generic or biosimilar ...

Humalog (insulin lispro) is a prescription drug that’s used to help treat diabetes. Humalog comes as a liquid solution for infusion or injection under the skin. Humalog comes in two versions: Humalog ...

DANBURY, CT--(Marketwired - January 07, 2015) - Biodel Inc. (BIOD) announced positive preliminary results from Study 3-151, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated ...

Lilly announced that 3mL (300-unit) vials of Humalog (insulin lispro [recombinant]) and Humulin R U-100 (regular insulin [human, recombinant]) will be made available to hospitals in January 2010.

The new smaller vial - for Lilly's Humalog® (insulin lispro injection [rDNA origin]) and Humulin® R-U100 (regular insulin human injection, USP [rDNA origin)]) - is intended to provide hospitals more ...